Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02734069 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Fat-free Mass in the Carboplatin Calculated Dose and Chemotherapeutic Toxicity in Patients With Advanced NSCLC

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Jul 2025 to Dec 2026
    • Study completion date: Dec 2025 to Dec 2027
    v5
  2. Primary completion date: Jul 2024 to Jul 2025v4
  3. Primary completion date: Jul 2017 to Jul 2024
    • Study completion date: Dec 2017 to Dec 2025
    v3
  4. Primary endpoints: 1 to 2v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study evaluate the association of body composition (mainly free-fat mass), clinical and biochemical parameters with development of toxicity in patients under treatment with Carboplatin/Paclitaxel in advanced NSCLC.
Trial Details
NCT Number NCT02734069
Lead Sponsor Instituto Nacional de Cancerologia de Mexico
Conditions
(from sponsor)		 Lung Cancer, Sarcopenia, Toxicity
Related terms Lung Neoplasms, Sarcopenia
Enrollment 132 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov